
Edward Raymond
Examiner (ID: 8523, Phone: (571)272-2221 , Office: P/2857 )
| Most Active Art Unit | 2857 |
| Art Unit(s) | 2857 |
| Total Applications | 1533 |
| Issued Applications | 1393 |
| Pending Applications | 52 |
| Abandoned Applications | 93 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19948619
[patent_doc_number] => 12319968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Gene mutations and copy number alterations of EGFR, KRAS and MET
[patent_app_type] => utility
[patent_app_number] => 17/383390
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4865
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17383390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/383390 | Gene mutations and copy number alterations of EGFR, KRAS and MET | Jul 21, 2021 | Issued |
Array
(
[id] => 18537865
[patent_doc_number] => 20230242968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => KITS AND METHODS USING COMBINED SAMPLES TO IMPROVE SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 18/015885
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5727
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015885
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015885 | KITS AND METHODS USING COMBINED SAMPLES TO IMPROVE SENSITIVITY | Jul 12, 2021 | Pending |
Array
(
[id] => 18583255
[patent_doc_number] => 20230265515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => METHOD FOR DETECTING SEVERITY OF ATOPIC DERMATITIS
[patent_app_type] => utility
[patent_app_number] => 18/015311
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015311
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015311 | METHOD FOR DETECTING SEVERITY OF ATOPIC DERMATITIS | Jul 8, 2021 | Pending |
Array
(
[id] => 18537881
[patent_doc_number] => 20230242984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => SEX DETERMINATION MARKERS IN MULLETS AND METHODS OF USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/004788
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004788
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004788 | SEX DETERMINATION MARKERS IN MULLETS AND METHODS OF USING THEREOF | Jul 6, 2021 | Pending |
Array
(
[id] => 18552486
[patent_doc_number] => 20230250496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => RAPID DETECTION KIT FOR HUMAN PATHOGENIC CORONAVIRUSES: BETACORONAVIRUS GROUP B/C AND SARS-COV-2
[patent_app_type] => utility
[patent_app_number] => 18/003413
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003413
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/003413 | RAPID DETECTION KIT FOR HUMAN PATHOGENIC CORONAVIRUSES: BETACORONAVIRUS GROUP B/C AND SARS-COV-2 | Jul 1, 2021 | Abandoned |
Array
(
[id] => 17314955
[patent_doc_number] => 20210404003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => DNA METHYLATION AND GENOTYPE SPECIFIC BIOMARKER FOR PREDICTING POST-TRAUMATIC STRESS DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/362273
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17362273
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/362273 | DNA methylation and genotype specific biomarker for predicting post-traumatic stress disorder | Jun 28, 2021 | Issued |
Array
(
[id] => 19778781
[patent_doc_number] => 12227805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Genetic test for liver copper accumulation in dogs
[patent_app_type] => utility
[patent_app_number] => 17/360692
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 27328
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17360692
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/360692 | Genetic test for liver copper accumulation in dogs | Jun 27, 2021 | Issued |
Array
(
[id] => 19142589
[patent_doc_number] => 20240141435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => Methods for detecting and predicting cancer
[patent_app_type] => utility
[patent_app_number] => 18/009943
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009943
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009943 | Methods for detecting and predicting cancer | Jun 16, 2021 | Abandoned |
Array
(
[id] => 18988167
[patent_doc_number] => 20240060136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => METHODS FOR DETECTING AND PREDICTING GRADE 3 CERVICAL EPITHELIAL NEOPLASIA (CIN3) AND/OR CANCER
[patent_app_type] => utility
[patent_app_number] => 18/009957
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 195872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009957
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009957 | METHODS FOR DETECTING AND PREDICTING GRADE 3 CERVICAL EPITHELIAL NEOPLASIA (CIN3) AND/OR CANCER | Jun 16, 2021 | Pending |
Array
(
[id] => 20173265
[patent_doc_number] => 12391999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Methods and kits for classifying cannabinoid production in cannabis plants
[patent_app_type] => utility
[patent_app_number] => 17/346709
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 10
[patent_no_of_words] => 9950
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/346709 | Methods and kits for classifying cannabinoid production in cannabis plants | Jun 13, 2021 | Issued |
Array
(
[id] => 17156487
[patent_doc_number] => 20210317538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => DETECTING PANCREATIC HIGH-GRADE DYSPLASIA
[patent_app_type] => utility
[patent_app_number] => 17/347027
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/347027 | DETECTING PANCREATIC HIGH-GRADE DYSPLASIA | Jun 13, 2021 | Abandoned |
Array
(
[id] => 17112256
[patent_doc_number] => 20210292853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => DETECTION OF CLDN18-ARHGAP6 FUSION GENE OR CLDN18-ARHGAP26 FUSION GENE IN PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 17/336935
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/336935 | DETECTION OF CLDN18-ARHGAP6 FUSION GENE OR CLDN18-ARHGAP26 FUSION GENE IN PANCREATIC CANCER | Jun 1, 2021 | Abandoned |
Array
(
[id] => 18170602
[patent_doc_number] => 20230037213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => CHROMOSOME SEGMENT DERIVED FROM GOSSYPIUM ANOMALUM (G. ANOMALUM) LEADING TO LETHAL PHENOTYPE IN GOSSYPIUM HIRSUTUM (G. HIRSUTUM), AND MOLECULAR MARKERS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/783664
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/783664 | CHROMOSOME SEGMENT DERIVED FROM GOSSYPIUM ANOMALUM (G. ANOMALUM) LEADING TO LETHAL PHENOTYPE IN GOSSYPIUM HIRSUTUM (G. HIRSUTUM), AND MOLECULAR MARKERS THEREOF | Jun 1, 2021 | Abandoned |
Array
(
[id] => 18612756
[patent_doc_number] => 20230279491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => TREATMENTS FOR A SUB-POPULATION OF INFLAMMATORY BOWEL DISEASE PATIENTS
[patent_app_type] => utility
[patent_app_number] => 18/008146
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99951
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008146
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008146 | TREATMENTS FOR A SUB-POPULATION OF INFLAMMATORY BOWEL DISEASE PATIENTS | May 31, 2021 | Pending |
Array
(
[id] => 17482701
[patent_doc_number] => 20220090205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => METHODS FOR DIAGNOSING AND TREATING CANCER BY MEANS OF THE EXPRESSION STATUS AND MUTATIONAL STATUS OF NRF2 AND DOWNSTREAM TARGET GENES OF SAID GENE
[patent_app_type] => utility
[patent_app_number] => 17/335526
[patent_app_country] => US
[patent_app_date] => 2021-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335526
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/335526 | METHODS FOR DIAGNOSING AND TREATING CANCER BY MEANS OF THE EXPRESSION STATUS AND MUTATIONAL STATUS OF NRF2 AND DOWNSTREAM TARGET GENES OF SAID GENE | May 31, 2021 | Abandoned |
Array
(
[id] => 18469304
[patent_doc_number] => 20230203588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => MARKERS AND CELLULAR ANTECEENTS OF RHEUMATOID ARTHRITIS FLARES
[patent_app_type] => utility
[patent_app_number] => 17/928513
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/928513 | MARKERS AND CELLULAR ANTECEENTS OF RHEUMATOID ARTHRITIS FLARES | May 27, 2021 | Pending |
Array
(
[id] => 17274857
[patent_doc_number] => 20210381055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => METHODS OF DETECTING AND TREATING MULTIPLE SYSTEM ATROPHY
[patent_app_type] => utility
[patent_app_number] => 17/334683
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334683
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/334683 | Methods of detecting and treating multiple system atrophy | May 27, 2021 | Issued |
Array
(
[id] => 18511722
[patent_doc_number] => 20230227909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => METHODS OF DETERMINING THE ETIOLOGY OF ACUTE ISCHEMIC STROKES
[patent_app_type] => utility
[patent_app_number] => 17/999659
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5219
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999659 | METHODS OF DETERMINING THE ETIOLOGY OF ACUTE ISCHEMIC STROKES | May 25, 2021 | Pending |
Array
(
[id] => 18837927
[patent_doc_number] => 11845990
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype
[patent_app_type] => utility
[patent_app_number] => 17/327102
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 3917
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327102 | Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype | May 20, 2021 | Issued |
Array
(
[id] => 17156486
[patent_doc_number] => 20210317537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => NOVEL MRNA BASED PROGNOSTIC INDEX DERIVED FROM DIFFERENTIAL EXPRESSION ANALYSIS IMPROVES OVERALL SURVIVAL ESTIMATES IN GLIOBLASTOMA
[patent_app_type] => utility
[patent_app_number] => 17/320739
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320739 | NOVEL MRNA BASED PROGNOSTIC INDEX DERIVED FROM DIFFERENTIAL EXPRESSION ANALYSIS IMPROVES OVERALL SURVIVAL ESTIMATES IN GLIOBLASTOMA | May 13, 2021 | Pending |